Treatment

Isavuconazole in Aspergillosis

A balanced guide for…

Infographic comparing 0.9%, 3%, 6% and 7% nebulised saline for mucus clearance and bronchiectasis.

Nebulised saline: what do 0.9%, 3%, 6% and 7% actually mean?

Patient and clinician discussing the future of aspergillosis care, with lung, blood-test and research illustrations.

The Future of Aspergillosis Care: Earlier Diagnosis, New Treatments and Personalised Support

Illustration of a T cell recognising a fungal antigen and coordinating an immune response near Aspergillus fumigatus.

Is a vaccine for chronic pulmonary aspergillosis (CPA) being developed?

Illustration showing monoclonal antibodies binding Aspergillus fumigatus and helping macrophages recognise and engulf the fungus.

Beyond antifungal drugs: could antibodies help the immune system fight Aspergillus?

Patient talking with a healthcare professional about support and treatment choices

Complementary therapies and aspergillosis: finding relief without losing sight of treatment

Patient receiving a specialist antifungal medicine delivery at home

Getting specialist antifungal medicines delivered to your home: a guide to NHS homecare

Clinician reviewing immune-suppressing medicines and blood test results alongside lung and Aspergillus imagery.

Immune-Suppressing Medicines and Aspergillosis: When Does Treatment Change the Risk?

Scientific illustration showing amphotericin B disrupting an Aspergillus fungal cell membrane during research into antifungal resistance.

Amphotericin B resistance in Aspergillus: protecting an important treatment for the future

Person reducing respiratory infection risk through ventilation, handwashing, vaccination and mask use

Respiratory Infections and Aspergillosis: Reducing Your Risk and Knowing When to Seek Help

by Beth Bradshaw